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Summary
 
CD3-
 
z
 
/
 
h
 
–deficient mice have small thymuses containing cells that show a profound reduction
in the surface levels of T cell receptors and terminate their differentiation at the CD4
 
1
 
CD8
 
1
 
stage. Rather unexpectedly, CD3
 
2
 
 
 
or
 
 
 
very
 
 
 
low
 
 single positive T cells accumulate over time in the
spleen and lymph nodes of CD3-
 
z
 
/
 
h
 
–deficient mice after a process dependent on MHC ex-
pression. Fusion of these peripheral T cells with a CD3-
 
z
 
–positive derivative of the BW5147
TCR-
 
a
 
2
 
/
 
b
 
2
 
 thymoma resulted in hybridomas that do express an heterogeneous set of T cell
receptor 
 
a
 
/
 
b
 
 dimers at their surface and at density comparable to those found in hybridomas
derived from wild-type peripheral T cells. We have investigated the specificities of these T cell
receptors using spleen cells from congenic and mutant mouse strains, and showed that the ma-
jority of them readily recognized self-MHC class I or class II molecules. These results demon-
strate that by increasing the density and/or output of the T cell receptors expressed in periph-
eral T cells, one can confer them with the capacity to respond to normal density of self-MHC
molecules.
 
M
 
ost peripheral T cells express clonally variable anti-
gen receptors (TCRs) made up of 
 
a
 
 and 
 
b
 
 chains
and specific for peptide antigens bound to class I and II
products of the MHC. Peripheral T cells derive from the
thymus where their fate is determined on the basis of the
specificity of the TCR-
 
a
 
/
 
b
 
 heterodimers they express. For
instance, CD4
 
1
 
CD8
 
1
 
 thymocytes appear to be rescued
from programmed cell death and induced to differentiate
into single positive cells only if their TCRs bind with low
affinity to the self peptide/MHC complexes expressed on
thymic stromal cells. Remaining CD4
 
1
 
CD8
 
1
 
 thymocytes
with TCRs that do not react, or react with too high an af-
finity with self peptide/MHC complexes, either die by apop-
tosis or are censored by a variety of nondeletional mecha-
nisms (for review see reference 1). This thymic selection
process, often denoted as TCR-
 
a
 
/
 
b
 
–dependent selection,
contributes to purge the periphery from autoreactive T
cells and populate it with only those T cells capable of
binding self-MHC products complexed to nonself pep-
tides. The above findings have been incorporated into a
“signal strength” model of TCR-
 
a
 
/
 
b
 
 selection asserting
that the signaling cassettes operated by the TCR and linked
to positive and negative selection have different activation
thresholds, the cassette for positive selection having a lower
threshold of activation than that for negative selection (2–4).
Furthermore, considering that most self peptide/MHC
complexes are ubiquitously expressed by cells in the thy-
mus and periphery (5), the inability of mature T cells to re-
act detectably upon reencountering their corresponding
selecting self peptide/MHC ligands has been generally ac-
counted for by the fact that they have higher activation
threshold and/or lower TCR-signaling output than imma-
ture CD4
 
1
 
CD8
 
1
 
 thymocytes (6).
Analysis of mice deprived of TCR-
 
a
 
 polypeptide, ZAP-70
protein tyrosine kinase, as well as MHC class I and II prod-
ucts further supported the view that signaling via fully assem-
bled TCR/CD3 complexes is required for TCR-
 
a
 
/
 
b
 
–depen-
dent selection and the subsequent accumulation of single
positive T cells in the periphery (for review see reference
7). We (8) and others (9, 10) have recently characterized
mice lacking both the CD3-
 
z
 
 and -
 
h
 
 polypeptides. CD3-
 
z
 
and -
 
h
 
 originate from a single gene (CD3-
 
z
 
/
 
h
 
) by way of
alternative splicing, and contribute to the efficient transport
of the TCR/CD3 complex to the cell surface and to its
signaling function via their immunoreceptor tyrosine-based
activation motifs (11–13). Studies using cell lines have
shown that in the absence of CD3-
 
z
 
 and -
 
h
 
, very low levels
of subcomplexes made of TCR-
 
a
 
/
 
b
 
, CD3-
 
d
 
/
 
e
 
, and -
 
g
 
/
 
e
 
dimers can leak to the cell surface (14). After stimulation
with high density of immobilized anti–CD3-
 
e
 
 mAbs, or
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high concentrations of antigen or superantigen (13, 15), these
subcomplexes can still minimally signal via their CD3-
 
d
 
/
 
e
 
and -
 
g
 
/
 
e
 
 autonomous transduction modules (13). CD3-
 
z
 
/
 
h
 
2
 
/
 
2
 
 mutant mice have small thymuses (2.4 
 
3
 
 10
 
7
 
 cells on
average) containing cells that show a profound reduction in
the surface levels of TCR and are arrested at the CD4
 
1
 
CD8
 
1
 
 stage of development. The CD3-
 
z
 
/
 
h
 
2
 
/
 
2
 
 mutation
had no effect on the rearrangements of the TCR-
 
b
 
 genes.
In contrast, CD3-
 
z
 
/
 
h
 
2
 
/
 
2
 
 thymocytes showed low levels of
TCR-
 
a
 
 rearrangements and transcripts, providing a poten-
tial for the synthesis of only limited amounts of TCR-
 
a
 
polypeptides (7, 10). Complementation of CD3-
 
z
 
/
 
h
 
2
 
/
 
2
 
mice with several matched pairs of TCR-
 
a
 
 and -
 
b
 
 trans-
genes does not lead to further maturation into CD4
 
1
 
CD8
 
2
 
and CD4
 
2
 
CD8
 
1
 
 single positive cells (Ardouin, L., A. Gillet,
and M. Malissen, unpublished results). Therefore, the devel-
opmental blockade observed in CD3-
 
z
 
/
 
h
 
–deficient thy-
mocytes does not primarily result from their limited con-
tent of rearranged TCR-
 
a
 
 gene segments, but rather from the
fact that the low density at which they express TCR-
 
a
 
/
 
b 
 
/
CD3-
 
d
 
/
 
e 
 
/ CD3-
 
g
 
/
 
e
 
 subcomplexes at the cell surface pre-
vents most of them from participating in TCR-
 
a
 
/
 
b
 
 selec-
tion. Despite the almost complete absence of single positive
thymocytes noted in CD3-
 
z
 
/
 
h
 
2
 
/
 
2
 
 mice, the spleen and
lymph nodes of 3-mo-old CD3-
 
z
 
/
 
h
 
2
 
/
 
2
 
 mice contained a
normal ratio of CD4
 
1
 
CD8
 
2
 
 and CD4
 
2
 
CD8
 
1
 
 cells express-
ing barely detectable levels of TCR/CD3 complexes (8, 10).
It is therefore possible that in CD3-
 
z
 
/
 
h
 
2
 
/
 
2
 
 mice, TCR/CD3
subcomplexes deprived of CD3-
 
z/h dimers can be ex-
pressed at the cell surface in amounts not easily detectable
by flow cytometry, but sufficient to drive MHC-dependent
intrathymic (1) or extrathymic (16) selection events. Con-
sistent with the view that the peripheral T cells found in
CD3-z/h2/2 mice have not survived by chance in a pro-
cess independent of selection by MHC molecules, peripheral
CD41CD82 and CD42CD81 cells were greatly diminished
in CD3-z/h2/2 3 MHC class II2/2 and CD3-z/h2/2 3
MHC class I2/2 double mutants, respectively (17, and our
unpublished observations).
According to the signal strength model of TCR-a/b se-
lection, any experiments aiming at increasing the density of
self peptide/MHC complexes on antigen presenting cells
(e.g., as a result of synthetic self-peptide loading) should
trigger mature T cells previously selected on these ligands
(18, 19). Similarly, boosting the signaling capacity and/or
density of the TCR expressed by mature T cells should
confer them with the capacity to react to normal density of
self peptide/MHC complexes. Assuming that the single
positive T cells found in the periphery of CD3-z/h2/2
mice have been selected to survive via a process relying on
TCR expression and in a peptide/MHC-dependent man-
ner (see above), complementation of these cells with a
CD3-z gene should dramatically increase the surface den-
sity and signaling capacity of their TCR-a/b dimers and
provide a unique opportunity to investigate whether they
have consequently gained an antiself reactivity. We there-
fore analyzed the specificity of the single positive T cells
found in the periphery of CD3-z/h–deficient mice after
introduction of a CD3-z gene and restoration of normal
surface density of TCR/CD3 complexes harboring a com-
plete set of immunoreceptor tyrosine-based activation mo-
tifs. Our results showed that most of them are reactive to
self-MHC class I and II molecules.
Materials and Methods
Mice. The CD3-z/h–deficient mice have been described (8,
16, 20). These mice, originally on a C57BL/6 (H-2b) back-
ground, were crossed with the C57BL/6-H-2k congenic strain to
produce CD3-z/h–deficient mice that carry the H-2k haplotype.
The MHC class II–deficient mice (II0) (21) and b2-microglobu-
lin–deficient mice (b2m0; 22) have been bred for at least eight
generations on a C57BL/6 genetic background. Mice were
housed in a specific pathogen-free animal facility.
Cells. BW5147 TCR-a2b2 (hereafter referred to as BW2) is
a variant of the BW5147 thymoma lacking CD3-d, CD3-z/h,
and FceRIg transcripts as well as functional TCR a and b chain
genes (13, 23, 24, 25).
Purification of Single Positive T Cells from Spleen and Lymph Nodes.
Lymph node and spleen cells from several 3-mo-old CD3-z/h2/2
or CD3-z/h1/1 mice were pooled, and the single positive cells
purified using a high gradient magnetic cell separation system
(26). In brief, cells were first labeled with saturating levels of bio-
tinylated antibodies against CD4 and CD8. After washing off the
unbound mAbs, cells were stained with a fluorescein–streptavidin
conjugate (Immunotech, Marseille, France). Finally, biotinylated
superparamagnetic microparticles (Miltenyi Biotec., Sunnyvale,
CA) were attached to the remaining free sites of the streptavidin
conjugate bound to the cell surface, and the magnetic cell frac-
tions isolated on a high gradient magnetic cell separation system
separator. In our experience, this protocol leads to cell suspen-
sions containing .96% labeled cells.
Preparation of T Cell Hybridomas. A CD3-z positive derivative
of the BW2 thymoma was constructed by protoplast fusion using
plasmid pHbAPr-his–CD3-z (13). Histidinol-resistant clones were
isolated and tested for the intracytoplasmic expression of CD3-z by
Western blot analysis. A transfectant, hereafter denoted as BW2z,
and expressing levels of CD3-z polypeptide similar to the BWdz
transfectant (13), was selected and fused to purified peripheral single
positive T cells (see above). After hypoxanthine/aminopterin/
thymidine selection, the resulting T cell hybridomas were analyzed by
staining for cell surface expression of CD3-e. CD3-e positive hy-
bridomas were cloned and further characterized as described below.
Antibodies and Flow Cytometric Analysis. Before staining, spleen
and lymph node cells were preincubated on ice for at least 10 min
with polyclonal mouse and rat Ig to prevent FcR-mediated ab-
sorption of antibodies to cells. 2 3 105 cells were subsequently
stained with saturating levels of antibodies for 30 min at 48C.
2–10 3 103 gated events were acquired using a FACScanÒ flow
cytometer and analyzed with Lysis II software. FITC-conjugated
anti-CD4 antibody was purchased from CALTAG Labs. (South
San Francisco, CA). Biotinylated FITC- or PE-conjugated anti-
bodies against CD3, CD4, CD8, CD25, CD44, CD69, CD62,
CD122, Fas, and NK1.1, were purchased from PharMingen (San
Diego, CA). Biotinylated antibodies were revealed with strepta-
vidin-tricolor (CALTAG Labs.). For flow cytometric analyses, T
cell hybridomas were first incubated with saturating concentra-
tions of mAb directed against CD3-e (KT3), TCR-b (H57-597),
TCR-d (GL3), CD4 (RL172.4), CD8 (3.168.81), or the products
of various Va and Vb gene segments, washed, and then stained709 Lin et al.
with saturating concentration of an F(ab9)2 fragment of a FITC-
conjugated rabbit anti-mouse Ig (Cappel Labs., Malvern, PA).
Stimulation of T Cell Hybridomas. In brief, 0.25 ml microcul-
tures were prepared containing 105 responding cells and 106 irra-
diated (20 Gy) splenocytes. For stimulation with the anti–CD3-e
antibody 2C11, the bottom of microtiter wells was precoated
with 50 ml of a 10 mg/ml solution of antibody. Cultures were for
20 h, at which time culture supernatants were harvested and as-
sayed for the level of IL-2 using the IL-2–dependent T cell line
CTL-L. The amount of [3H]thymidine incorporated into CTL-L
cells was measured by direct b counting (Matrix 96 direct beta
counter; Packard Instrs., Meriden, CT). Considering that the var-
ious hybridomas did not respond to the same extent to anti–
CD3-e stimulation, the levels of IL-2 production observed in re-
sponse to irradiated splenocytes of H-2b or H-2k haplotypes were
normalized for each hybridoma by using the following formula:
([3H]thymidine incorporation in response to splenocytes of a
given haplotype / [3H]thymidine incorporation in response to
immobilized anti–CD3-e) 3 100. The two percentages obtained
for each hybridoma were plotted on a graph to reflect their re-
spective abilities to respond to H-2b or H-2k splenocytes.
Results
Age-associated Accumulation of Peripheral Single Positive T
Cells in CD3-z/h–deficient Mice. When analyzed by flow
cytometry for the expression of CD4 and CD8 molecules,
thymuses from 1- to 3-mo-old CD3-z/h2/2 mice were
found to contain dramatically fewer single positive cells
than age-matched wild-type thymuses (Fig. 1). Moreover,
most of these cells expressed residual levels of CD25 mole-
cules and probably corresponded to “immature” single pos-
itive cells on the way to becoming double positive cells
(20). Despite the near total absence of mature single posi-
tive thymocytes, Thy11-single positive T cells were found
to accumulate over time in lymph nodes of CD3-z/h2/2
mice (Fig. 1, right), but in smaller numbers than those from
age-matched wild-type littermates (CD3-z/h1/1, n 5 5;
average 13 3 106; CD3-z/h2/2, n 5 7, average 5.8 3
106). Similar to CD3-z/h2/2 thymocytes, the single posi-
tive cells found in CD3-z/h2/2 lymph nodes expressed
levels of TCR/CD3 complexes barely detectable by flow
cytometry (Fig. 2; 8–10, 17). When the lymph node T cell
populations found in 3-mo-old wild-type and CD3-z/h2/2
mice were compared for the expression of various cell sur-
face markers, they both showed identical staining profiles
for CD25, CD62, CD69, CD122, and Fas molecules as
well as a NK1.12 phenotype (Fig. 2 and data not shown).
The most striking difference was seen in the level of ex-
pression of CD44 which was highly expressed by all the sin-
gle positive cells found in CD3-z/h2/2 lymph nodes (Fig. 2).
A corresponding population of Thy11, CD32 or very low
single positive T cells was also present in the spleen of
3-mo-old CD3-z/h–deficient mice (data not shown). It
should be noted that we have not been able to extend our
analysis of CD3-z/h2/2 over a longer time because mice
die around 4 mo of age after developing a chronic intestinal
inflammation, characterized by diarrhea and wasting, simi-
lar to that previously documented in cytokine or TCR
mutant mice (27).
Normal Levels of TCR-ab Heterodimer Can Be Rescued
from CD3-z/h2/2 Peripheral T Cells upon Transfer of a CD3-z
Gene. To assess whether the single positive T cells accu-
mulating at a low rate in the periphery of CD3-z/h2/2
mice synthesized TCR-ab heterodimers, we intended to
fuse these cells with the BW2 thymoma and convert them
into T cell hybridomas. BW2 is a variant of the BW5147
thymoma that lacks functional TCR-a and -b genes and
has been extensively used to analyze the specificity of TCR
expressed on heterogeneous populations of nontransformed
T cells (e.g., references 28 and 29). Considering that BW2
cells do not transcribe the CD3-z/h gene (13) and are, as
such, unsuitable for experiments involving CD3-z/h–defi-
cient T cells, we first transfected them with a plasmid di-
recting the expression of CD3-z polypeptides. Because the
CD3-h polypeptide does not appear endowed with unique
signaling capacities relative to CD3-z (30, 31), we limited
our effort to the construction of a derivative of BW2, de-
Figure 1. CD41CD82 and CD42CD81 cells accumulate over time in
the lymph nodes of CD3-z/h–deficient mice. Cells from thymus and
lymph nodes were isolated from 1- to 3-mo-old CD3-z/h–deficient mice
and analyzed by two-color flow cytometry for the expression of CD4
versus CD8. The percentage of cells found in each quadrant is indicated.
Most of the lymph node cells scoring as CD42CD82 were brightly
stained with an anti-B220 antibody (RA3-6B2), and likely belong to the
B cell lineage.710 T Cells Selected with Low TCR Density
noted BW2z, and expressing only the CD3-z products (see
Materials and Methods). As expected, transfection into
BW2 of the CD3-z gene alone did not lead to the appearance
of surface molecules reactive with either an anti–CD3-e or
anti–TCR-b mAb (Fig. 3, top). Cells from spleen, inguinal,
and mesenteric lymph nodes from 3-mo-old CD3-z/h2/2
mice of H-2b (Z2B) or H-2k (Z2K) haplotypes were iso-
lated and separately fused with BW2z. Sets of control hy-
bridomas were prepared similarly from spleen and lymph
node cells from 3-mo-old wild-type littermates of H-2b
(Z1B) or H-2k (Z1K) haplotypes. Once produced, T cell
hybridomas from individual wells were expanded briefly
and analyzed for expression of CD3 at their surface. 20% of
the hybridomas from CD3-z/h1/1 mice expressed CD3 at
their surface, the remaining CD3-negative hybridomas be-
ing likely TCR loss variants. Of the hybridomas derived
from CD3-z/h2/2 mice, 5% did express CD3 at their sur-
face and in amounts no lower than on hybridomas derived
from CD3-z/h1/1 mice (compare hybridomas Z1K 2.3,
Z2B17.20, and Z2K3.13 in Fig. 3). The lack of detectable
CD3 expression on a larger proportion of the hybridomas
derived from CD3-z/h2/2 mice probably resulted from
the fact that some of them had additionally lost the trans-
fected CD3-z gene during their establishment. All the
CD31 hybridomas (10 from CD3-z/h2/2, H-2b animals, 8
from CD3-z/h2/2, H-2k animals, and 10 from CD3-z/h1/1
animals of H-2b or H-2k haplotypes) were cloned and fur-
ther analyzed using antibodies specific for the TCR-a/b,
TCR-g/d, CD4, or CD8 molecules. All the CD31 hybri-
domas were readily stained with an antibody against the
constant region of the TCR-b chain (Fig. 3 and data not
shown). When further analyzed with a panel of anti-Va
and anti-Vb mAb, they were found to express the products
of gene segments belonging to the Va2, Va3.2, Va8, Vb2,
Vb6, Vb8, Vb12, or Vb14 subfamilies. These results sug-
gest that the CD31 hybridomas derived from CD3-z/h2/2
and CD3-z/h1/1 animals are not grossly skewed toward a
peculiar Va or Vb usage. Approximately half of the CD31
hybridomas displayed a CD41CD82 phenotype (Fig. 3).
Considering that BW5147 and its derivatives have been
shown to contribute trans-acting factors capable of silencing
the expression of the CD8-a gene (32), it is possible that
the CD42CD82 phenotype of some of the remaining hy-
bridomas resulted from their derivation from T cells be-
longing to the CD81 lineage.
Recognition of Conventional Self-MHC Molecules by the Ma-
jority of TCR-a/b1 Hybridomas Derived from CD3-z/h2/2
Mice. To examine the specificities of the heterogeneous
TCR-a/b dimers expressed on the Z2B and Z2K sets of
hybridomas, we tested them for IL-2 production in re-
sponse to spleen cells from C57BL/6 or C57BL/6-H-2k
mice. All the hybridomas were capable of IL-2 production
in response to immobilized anti–CD3-e mAb. Hybridomas
from CD3-z/h2/2, H-2b animals showed three distinct
Figure 2. Most of the CD32 peripheral single positive T cells found in
CD3-z/h–deficient mice display constitutively upregulated levels of
CD44. Lymph node cells from 3-mo-old CD3-z/h2/2 and -z/h1/1 mice
were analyzed by three-color flow cytometry for CD4 and CD8 expres-
sion in combination with various cell surface markers. Histograms show
the expression of the markers indicated on the left on gated CD41CD82
cells from CD3-z/h2/2 and -z/h1/1 mice. Similar patterns were ob-
served after gating on CD42CD81 cells. Each histogram is compared
with a negative control histogram obtained after staining with isotype-
matched negative control antibodies (dotted lines).
Figure 3. Fusion of CD3-z/h2/2 peripheral single positive T cells with
BW2z, a CD3-z1 derivative of the BW2 thymoma, results in hybridomas
expressing TCR-a/b complexes at their surface. BW2z was fused to sin-
gle positive T cells isolated from the spleen and lymph nodes of 3-mo-old
CD3-z/h2/2 or -z/h1/1 mice. The BW2z fusion partner and the result-
ing hybridomas were analyzed by flow cytometry after staining with the
anti–CD3-e antibody KT3, the anti–TCR-b antibody H57-597, the
anti-CD4 antibody RL172.4, or the anti-CD8 antibody 3.168.81. Con-
sidering that BW2z contributed trans-acting factors which inhibit the ex-
pression of the CD8-a gene in the resulting hybridomas (see text), the
histograms obtained after staining with an anti–CD8-a antibody were
used as genuine negative control histograms.711 Lin et al.
patterns of response. As shown in Fig. 4 B, one hybridoma
(Z2B17.20) failed to react with H-2b or H-2k splenocytes,
while another one (Z2B21.17) reacted with both H-2k and
H-2b splenocytes and produced IL-2 when grown in me-
dium alone. However, the most remarkable pattern of re-
activity was observed with the eight remaining Z2B hybri-
domas in that they reacted with C57BL/6 syngeneic spleen
cells but failed to respond with spleen cells prepared from
congenic C57BL-6-H-2k mice. (This major reactivity pat-
tern is illustrated by hybridoma Z2B5.16 in Fig. 4 B). On
the other hand, six of the eight hybridomas derived from
CD3-z/h2/2, H-2k animals showed a reciprocal pattern of
reactivity. For example, as illustrated in Fig. 4 C for hybri-
doma Z2K8.36, they did recognize C57BL/6-H-2k cells,
but not C57BL/6 cells. The two remaining hybridomas of
the Z2K set reacted with both spleen cell populations but,
in contrast to hybridoma Z2B21.17, did not produce any
detectable IL-2 when cultured in medium alone (compare
hybridomas Z2K37.4 and Z2B21.17 in Fig. 4). Despite the
expression of TCR associated with the same complement
of CD3 polypeptides and in amounts comparable to or
even greater than those found at the surface of the Z2B and
Z2K sets of hybridomas, none of the T cell hybridomas de-
rived from CD3-z/h1/1 animals had autoreactivity (sets
Z1B and Z1K in Fig. 4 A). The consistency of the latter
result with previous reports obtained with the BW2 fusion
partner (28, 29), clearly indicates that fusion with the
BW2z derivative does not in itself confer some artifactual
reactivities to the resulting hybridomas. As summarized in
Fig. 5, these results showed that the majority of the TCR-
a/b1 hybridomas established from CD3-z/h2/2 animals
specifically reacted with syngeneic spleen cells.
To investigate the nature of the ligands recognized by
the hybridomas derived from CD3-z/h2/2 mutant mice,
we next tested the panel of Z2B hybridomas with spleen
cells from mutant MHC class II– or b2m–deficient mice
(21, 22). Because both of these mutant mice were available
only on a C57BL/6 background, we had to limit our anal-
ysis to the Z2B set of hybridomas (Table I). If we omit the
Z2B21.17 hybridoma from further analysis because it pro-
duced IL-2 in the presence of medium alone and with all
tested cells, six hybridomas were well stimulated by b2m–
deficient spleen cells, but not by splenocytes from MHC
class II–deficient mice, whereas the remaining Z2B8.12
and Z2B2.8 hybridomas showed a reciprocal pattern of
reactivity. Consistent with the observation that normal
Figure 4. Specificity of hybri-
domas generated from single
positive peripheral T cells iso-
lated from wild-type mice of
H-2b or H-2k haplotypes (A),
CD3-z/h2/2 mutant mice of
H-2b (B), or H-2k (C) haplotypes.
IL-2 production of the various hy-
bridomas was measured after incu-
bation without any stimulus (Me-
dium), with irradiated C57BL/6
(H-2b) or C57BL/6-H-2k (H-2k)
splenocytes (106 cells/well), or in
wells coated with the anti–
CD3-e mAb 2C11 (10 mg/ml).
Figure 5. Most of the TCR-
a/b1 T cell hybridomas derived
from the single positive cells
found in the periphery of 3-mo-
old CD3-z/h2/2 mice display
antiself reactivity. T cell hybri-
domas derived from wild-type
mice (CD3-z/h1/1) of H-2b or
H-2k haplotypes (left) or CD3-
z/h2/2 mutant mice of H-2b
(middle) or H-2k haplotype (right)
were tested individually for their
ability to respond to irradiated
spleen cells from wild-type mice
of H-2b (C57BL/6) or H-2k
(C57BL/6-H-2k) haplotype. In
parallel experiments, hybridomas
were stimulated with an anti–
CD3-e mAb to assess for the integrity of their TCR signal transduction pathway (not shown). The IL-2 production values observed in response to H-2b
or H-2k spleen cells were normalized as a percentage of the IL-2 production values observed upon anti–CD3-e stimulation. The two percentages ob-
tained for each hybridoma reflect its ability to respond to H-2b (abscissa) or H-2k (ordinate) spleen cells. In the middle panel, the Z2B21.17 and Z2B17.20
hybridomas are specified by one and two arrows, respectively.712 T Cells Selected with Low TCR Density
CD42CD81 cells express MHC class I–restricted TCR and
CD41CD82 cells express MHC class II–restricted TCR (33),
four out of the six MHC class II–reactive Z2B hybridomas
were found to be CD41, whereas those activated by b2m–
deficient spleen cells were found to be CD42CD82. Alto-
gether, these reactivity patterns suggest that a large proportion
of the TCR-a/b1 hybridomas derived from CD3-z/h2/2
mice reacted against conventional self-MHC molecules.
Discussion
Thymocytes of mice deficient in CD3-z/h gene express
at their surface very low levels of TCR/CD3 subcom-
plexes deprived of the CD3-z/h transduction module, and
as a result, appear to terminate their development at the
CD41CD81 stage (8–10). Unexpectedly, a population of
single positive T cells was found to accumulate over time
in the spleen and lymph nodes of these mice. Although the
reciprocal expression of the CD4 molecule and CD8-a/b
isoform at their surface suggested that these peripheral T
cells have matured via a thymus-dependent pathway (34,
35), it should be noted that, owing to the small size of the
CD3-z/h2/2 thymuses, it has not been possible yet to suc-
cessfully thymectomize CD3-z/h2/2 neonates to formally
establish the thymic origin of these cells. Irrespective of
their exact origin, the CD32 or very low cells present in the
spleen and lymph nodes of CD3-z/h2/2 mice accumulate
in a process dependent on the expression of MHC mole-
cule (17), and as shown in that paper, do contain TCR-a/b
heterodimers. Once expressed at the surface of T cell hy-
bridomas, at density comparable to wild-type T cells and
together with a complete constellation of CD3 subunits,
the CD4-associated TCR-a/b dimers present in CD3-z/
h2/2 peripheral T cells showed a reactivity toward self-
MHC class II products, whereas those found on CD42
CD82 hybridomas and, presumably selected in association
with CD8, mostly recognized self-MHC class I products.
Importantly, none of the T cell hybridomas originating
from wild-type peripheral T cells were found capable of
reacting against self-MHC molecules. Three additional
points should be made. First, it should be emphasized that
the CD3-z/h–deficient mice used in the present study were
constructed from an embryonic stem cell line derived from
C57BL/6 mice (8), and maintained on either a C57BL/6
(H-2b) or C57BL/6-H-2k (H-2k) background. Considering
that the spleen cells used to stimulate the Z2B and Z2K sets
of hybridomas originate from C57BL/6 or C57BL/6-H-2k
mice, this experimental setting permitted us to exclude that
the patterns of reactivity displayed by these hybridomas are
directed against minor histocompatibility antigen(s). Sec-
ond, the peripheral T cells investigated here are distinct
from the TCR-a/b1 gut intraepithelial lymphocytes found
in CD3-z/h2/2 mice. In contrast to conventional mature
T lymphocytes, the latter express the CD8-a/a isoform,
bear TCR/CD3 complexes at their surface which incorpo-
rate FceRIg as one of their subunits, and are likely to be
extrathymically derived (8, 9, 36). Third, it has recently
been shown that negative selection of thymocytes occurs
primarily in the medulla (37). Considering that CD3-z/h–
deficient thymuses contain only residual foci of thymic me-
dulla (Naquet, P., M. Naspetti, and M. Malissen, unpublished
observations), negative selection may have been inopera-
tive in these mice. Thus, the single positive cells found in
their periphery may have undergone unopposed positive
selection (see below) and some of them been autoreactive
and exhibited overt signs of activation. However, the single
positive cells found in the spleen and lymph nodes of
3-mo-old CD3-z/h2/2 mice lack activation markers such
Table 1. Most of the Self-reactive CD31 Hybridomas Derived from H-2b, CD3-z/h2/2 Mice Recognize b2m– or MHC
Class II–dependent Ligands
IL-2 secreted (thymidine incorporation) in response to
Responder
hybridomas Medium
Immobilized
anti–CD3-e
H-2b, b2m1, II1
splenocytes
H-2b, b2m0, II1
splenocytes
H-2b, b2m1, II0
splenocytes
Z2B 8.12 214 14,459 3,952 761 3,368
Z2B 2.8 159 13,598 12,863 1,052 13,302
Z2B 53.4 228 13,455 7,625 7,010 308
Z2B 5.16 692 14,766 20,071 19,762 327
Z2B 103.1 56 11,923 4,955 4,766 53
Z2B 35.18 99 10,883 10,290 15,234 440
Z2B 170.3 181 15,651 3,512 4,141 191
Z2B 190.28 111 7,177 4,186 8,365 152
Z2B 21.1.7 19,115 20,040 15,096 13,961 12,046
Hybridomas (105) were cultured without any stimulus (medium), in wells coated with the anti–CD3-e mAb 2C11 or with irradiated splenocytes (106)
originating from wild-type, b2m–, or MHC class II–deficient mice of H-2b haplotype. Cultures were for 20 h, at which time 50 ml of supernatant
were collected and added undiluted to 50 ml of medium containing 5 3 103 cells of the IL-2 dependent line CTL-L. Growth of the CTL-L was es-
timated by [3H]thymidine incorporation after pulsing the wells with 1mCi [3H]TdR for 8 h. Mean values for duplicate samples are given.713 Lin et al.
as CD25 and CD69. Therefore, the TCR/CD3 subcom-
plexes that leak to the surface of these cells appear appro-
priately calibrated in relation to the CD3-z/h2/2 context,
and it is only after increasing artificially their surface density
and/or output that they react to self-MHC molecules.
One is led to ask whether our experimental protocol
might have resulted in the preferential fusion to the BW2z
partner of only those peripheral T cells that were in the
course of a self-MHC restricted response against infectious
agents. To test this possibility, we conduced a set of prelim-
inary experiments in which peripheral CD3-z/h2/2 cells
were prealably stimulated through the synergistic action of
phorbol 12-myristate 13-acetate and ionomycin, and found
that the reactivity of the resulting hybridomas was still bi-
ased toward self-MHC molecules (data not shown). Thus,
the unusual reactivity pattern observed for the CD3-z/h2/2–
derived hybridomas described in this paper (Fig. 5) does
not result from the fact that we have inadvertently favored
the fusion of preactivated CD3-z/h2/2 peripheral T cells.
However, it should be emphasized that these results do not
permit us to determine whether the ab-TCR rescued at
the surface of the CD3-z/h2/2–derived hybridomas have
previously undergone a process of MHC-dependent selec-
tion in the thymus or in the periphery (e.g., references 16
and 38). In any case, considering that the amount of MHC
ligands, CD4/CD8 coreceptors, and adhesion molecules
are not affected in CD3-z/h2/2 mice, we would like to
suggest that in CD3-z/h2/2 mice, only those T cells dis-
playing TCR with a high affinity for self peptide/MHC
complexes may survive preferentially and accumulate. Ac-
cordingly, upon engagement with self peptide/MHC com-
plexes, the small pool of high affinity TCR expected to be
available at the surface of these CD3-z/h2/2 cells is likely
to become rapidly exhausted, generating blunted intracel-
lular signals (39), capable of triggering survival signals, but
insufficient to reach the higher activation threshold needed
for negative selection. In contrast, once expressed in a
wild-type background, these very same TCR would be ex-
pected to trigger all the range of activation events up to
negative selection.
Our results are reminiscent of those obtained in mice
that lack b2m (40–42) and express MHC class I molecules
at levels considerably lower than normal. In these mice,
even the low levels of conformed class I heavy chains that
can reach the surface appeared capable of selecting CD81 T
cells, but in numbers lower than in wild-type mice. The
few CD81 T cells selected in b2m2/2 mice were capable
to mount strong allospecific responses after in vivo prim-
ing. However, in marked contrast to alloreactive CD81 T
cells generated in b2m-positive littermates, the alloreactive
T cells induced in a b2m2/2 context readily cross-reacted
toward syngeneic cells derived from b2m1/1 mice. As sug-
gested by Glas et al. (40), the most likely interpretation of
these data is that in b2m2/2 animals, negative selection
does not remove T cells capable of recognizing self pep-
tide/MHC complexes once expressed at physiological lev-
els. (Note that a more remote interpretation of these data
would be that the repertoire of peptides bound to MHC
class I molecules differs qualitatively between the b2m2/2
and wild-type settings.) Therefore, the amount of selecting
peptide/MHC ligands available in the thymus, as well as the
density and output of the TCR/CD3 complexes expressed
on thymocytes, contribute to set the signaling thresholds
for TCR-a/b selection. Consequently, by readjusting se-
lection windows, mutations in the CD3-z/h2 and b2m genes
resulted in two phenotypes which display striking symmet-
rical relationships.
Finally, on a more practical ground, peripheral blood
lymphocytes have been considered as primary targets for
gene therapy of inherited and acquired disorders of the im-
mune system. For instance, it has been suggested that trans-
duction of a CD3-e gene into the peripheral blood lym-
phocytes of an immunodeficient patient that lack CD3-e
chains should rescue a normal surface expression of their
TCR/CD3 complexes (43). However, on the basis of our
results, it can be predicted that when applied to mutant
cells that have already undergone a phase of internal cali-
bration in the primary and secondary lymphoid organs,
gene therapy trials aiming at correcting defects in T cell
recognition/activation events will result in the production
of cells reactive against self-MHC products.
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